Hurtado, R <br/><br/>
rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia.  [electronic resource] 

 -  Stem cells (Dayton, Ohio)  Mar 1995 
 - 112-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1066-5099 
<br/><br/><label>Standard No.: </label>10.1002/stem.5530130203  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--adverse effects<br/>Etoposide--administration & dosage<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Leukemia-Lymphoma, Adult T-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Recombinant Proteins--adverse effects